| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 25.771 | 28.835 | 30.240 | 30.539 | 28.464 | 26.902 | 28.230 | 41.923 | 31.315 | 37.603 |
| Total Income - EUR | 25.771 | 28.835 | 30.240 | 30.539 | 28.464 | 26.902 | 28.230 | 41.923 | 31.315 | 37.603 |
| Total Expenses - EUR | 24.717 | 26.720 | 24.044 | 26.075 | 26.996 | 28.341 | 23.340 | 32.960 | 29.355 | 32.500 |
| Gross Profit/Loss - EUR | 1.054 | 2.115 | 6.196 | 4.464 | 1.468 | -1.440 | 4.890 | 8.964 | 1.960 | 5.103 |
| Net Profit/Loss - EUR | 281 | 1.826 | 5.893 | 4.159 | 1.183 | -1.633 | 4.613 | 8.608 | 1.642 | 4.285 |
| Employees | 2 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Avantmedica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 3.111 | 2.059 | 2.580 | 3.936 | 4.544 | 3.590 | 6.803 | 15.631 | 17.120 | 21.825 |
| Inventories | 1.822 | 1.803 | 1.939 | 2.559 | 2.509 | 2.542 | 2.498 | 0 | 0 | 0 |
| Receivables | 0 | 126 | 87 | 91 | 36 | 8 | 0 | 0 | 12.207 | 12.562 |
| Cash | 1.290 | 130 | 554 | 1.286 | 1.999 | 1.040 | 4.305 | 15.631 | 4.914 | 9.263 |
| Shareholders Funds | -9.569 | -7.645 | -1.622 | 2.566 | 3.700 | 1.996 | 6.506 | 15.128 | 16.724 | 20.916 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 12.681 | 9.928 | 4.423 | 1.586 | 844 | 1.594 | 297 | 503 | 396 | 909 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Avantmedica Srl